ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,487.03
      0.25%
      US Tech 100
      19,430.40
      0.14%
      Dow Jones
      38,834.86
      0.15%
      Brent Oil
      84.695
      -0.11%
      Bitcoin
      64,976.57
      -0.25%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. KALA BIO Inc (KALA)

      7. KALA BIO Inc (KALA) News

      KALA

      KALA BIO (KALA)

      KALA BIO Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:KALA
      DateTimeSourceHeadlineSymbolCompany
      12/28/20224:05PMDow Jones NewsKala Pharma Shares More Than Triple After FDA Accepts IND for KPI-012NASDAQ:KALAKALA BIO Inc
      12/27/20224:49PMDow Jones NewsKala Pharmaceuticals Stock Jumps 79% as FDA Accepts Drug Application For Eye ConditionNASDAQ:KALAKALA BIO Inc
      12/27/20224:14PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:KALAKALA BIO Inc
      12/27/20224:01PMGlobeNewswire Inc.Kala Pharmaceuticals Announces FDA Acceptance of IND Application for KPI-012 for the Treatment of PCEDNASDAQ:KALAKALA BIO Inc
      12/09/20224:31PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:KALAKALA BIO Inc
      12/06/20227:01AMTipRanksAnalysts’ Top Healthcare Picks: Arrowhead Pharmaceuticals (ARWR), Kala Pharmaceuticals (KALA)NASDAQ:KALAKALA BIO Inc
      11/30/20226:20AMTipRanksAnalysts Offer Insights on Healthcare Companies: Biogen (BIIB), Horizon Therapeutics (HZNP) and Kala Pharmaceuticals (KALA)NASDAQ:KALAKALA BIO Inc
      11/28/20225:39PMDow Jones NewsKala Pharmaceuticals Shares Jump Nearly 20% on News of IND, Private PlacementNASDAQ:KALAKALA BIO Inc
      11/28/20224:02PMGlobeNewswire Inc.Kala Pharmaceuticals Announces Submission of Investigational New Drug Application for KPI-012 for the Treatment of Persistent Corneal Epithelial DefectNASDAQ:KALAKALA BIO Inc
      11/28/20224:01PMGlobeNewswire Inc.Kala Pharmaceuticals Announces Up to $31 Million Private Placement FinancingNASDAQ:KALAKALA BIO Inc
      11/09/20226:45AMTipRanksKala Pharmaceuticals (KALA) Gets a Buy from WedbushNASDAQ:KALAKALA BIO Inc
      11/08/20224:03PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:KALAKALA BIO Inc
      11/08/20228:00AMGlobeNewswire Inc.Kala Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate UpdateNASDAQ:KALAKALA BIO Inc
      11/01/20227:30AMGlobeNewswire Inc.Kala Pharmaceuticals Announces Appointment of Marjan Farid, M.D., to its Board of DirectorsNASDAQ:KALAKALA BIO Inc
      10/28/20224:17PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:KALAKALA BIO Inc
      10/21/202211:59AMTipRanksKala Plunges After Reverse Stock SplitNASDAQ:KALAKALA BIO Inc
      10/20/20227:30AMGlobeNewswire Inc.Kala Pharmaceuticals Announces Reverse Stock SplitNASDAQ:KALAKALA BIO Inc
      09/06/20228:00AMGlobeNewswire Inc.Kala Pharmaceuticals to Present at H.C. Wainwright 24th Annual Global Investment ConferenceNASDAQ:KALAKALA BIO Inc
      08/19/20224:01PMGlobeNewswire Inc.Kala Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)NASDAQ:KALAKALA BIO Inc
      08/19/20227:09AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:KALAKALA BIO Inc
      08/19/20227:01AMEdgar (US Regulatory)Securities Registration (section 12(g)) (8-a12g)NASDAQ:KALAKALA BIO Inc
      08/18/20224:01PMGlobeNewswire Inc.Kala Pharmaceuticals Announces Distribution of Series D Preferred Stock to Holders of its Common StockNASDAQ:KALAKALA BIO Inc
      08/15/20226:25AMTipRanksH.C. Wainwright Keeps Their Buy Rating on Kala Pharmaceuticals (KALA)NASDAQ:KALAKALA BIO Inc
      08/11/20227:02AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:KALAKALA BIO Inc
      08/11/20227:00AMGlobeNewswire Inc.Kala Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate UpdateNASDAQ:KALAKALA BIO Inc
      08/08/20229:00AMGlobeNewswire Inc.Kala Pharmaceuticals to Report Second Quarter 2022 Financial Results and Host Conference CallNASDAQ:KALAKALA BIO Inc
      08/04/20224:01PMGlobeNewswire Inc.Kala Pharmaceuticals to Participate in Upcoming Investor Conferences in AugustNASDAQ:KALAKALA BIO Inc
      07/22/20224:01PMGlobeNewswire Inc.Kala Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)NASDAQ:KALAKALA BIO Inc
      07/12/20225:11PMEdgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:KALAKALA BIO Inc
      07/12/20226:17AMTipRanksH.C. Wainwright Thinks Kala Pharmaceuticals’ Stock is Going to RecoverNASDAQ:KALAKALA BIO Inc
       Showing the most relevant articles for your search:NASDAQ:KALA